User profiles for Amelia Chiara Trombetta

Amelia Chiara Trombetta

Instituto de Medicina Molecular Joćo Lobo Antunes
Verified email at medicina.ulisboa.pt
Cited by 1578

Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort …

…, G Spadaro, C Agostini, C Milito, AC Trombetta… - Journal of clinical …, 2011 - Springer
A 5-years multicenter prospective study on 201 patients with common variable immunodeficiencies
and 101 patients with X-linked agammaglobulinemia over a cumulative follow-up …

[HTML][HTML] A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement

AC Trombetta, S Soldano, P Contini, V Tomatis… - Respiratory …, 2018 - Springer
Background Systemic sclerosis (SSc) is a disorder characterized by immune system
alterations, vasculopathy and fibrosis. SSc-related interstitial lung disease (ILD) represents a …

Effects of longterm treatment with bosentan and iloprost on nailfold absolute capillary number, fingertip blood perfusion, and clinical status in systemic sclerosis

AC Trombetta, C Pizzorni, B Ruaro, S Paolino… - The Journal of …, 2016 - jrheum.org
Objective. To quantify in patients with systemic sclerosis (SSc) the absolute nailfold capillary
number/mm (the absolute number of capillaries, observable in the first row, in 1 mm per field…

Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis

S Soldano, AC Trombetta, P Contini… - Annals of the …, 2018 - ard.bmj.com
An M2 pre-eminent phenotype has been postulated for SSc monocytes/macrophages. 2 The
aim of the study was to widen a phenotype characterisation (M1, M2 and mixed M1/M2) of …

[HTML][HTML] Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments

AC Trombetta, V Smith, E Gotelli, M Ghio, S Paolino… - PLoS …, 2017 - journals.plos.org
Objective Assessment of serum 25-hydroxyvitamin D (25(OH)D) correlations with clinical
parameters and evaluation of the efficacy of standard oral supplementation in systemic …

Quantitative alterations of capillary diameter have a predictive value for development of the capillaroscopic systemic sclerosis pattern

AC Trombetta, V Smith, C Pizzorni, M Meroni… - The Journal of …, 2016 - jrheum.org
Objective. To quantify earlier capillary diameter abnormalities, observed by nailfold
videocapillaroscopy (NVC), in primary Raynaud phenomenon (PRP) subjects compared with RP …

[HTML][HTML] Alternatively activated (M2) macrophage phenotype is inducible by endothelin-1 in cultured human macrophages

S Soldano, C Pizzorni, S Paolino, AC Trombetta… - PLoS …, 2016 - journals.plos.org
Background Alternatively activated (M2) macrophages are phenotypically characterized by
the expression of specific markers, mainly macrophage scavenger receptors (CD204 and …

Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA …

…, C Ickinger, K Melsens, Y Piette, AC Trombetta… - Autoimmunity …, 2018 - Elsevier
Objectives A reliable tool to evaluate flow is paramount in systemic sclerosis (SSc). We
describe herein on the one hand a systematic literature review on the reliability of laser speckle …

[HTML][HTML] Early myocardial damage and microvascular dysfunction in asymptomatic patients with systemic sclerosis: a cardiovascular magnetic resonance study with …

…, C Borrazzo, A Fiorelli, G Barchetti, AC Trombetta… - PLoS …, 2020 - journals.plos.org
Purpose Cardiac involvement in Systemic Sclerosis (SSc) is increasingly recognized as a
mayor cause of morbidity and mortality. The aim of present study is to investigate the early …

Advances in nailfold capillaroscopic analysis in systemic sclerosis

…, E Alessandri, AC Trombetta… - … of Scleroderma and …, 2018 - journals.sagepub.com
Systemic sclerosis is an autoimmune connective tissue disease characterized by early and
persistent microvascular impairment which leads to functional and organic manifestations, …